Fundz

vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer

PUBLIC · VTVTNov 02, 2023

Position

Chief Medical Officer

Company

vTv Therapeutics Inc.

Thomas Strack
tstrack@vtvtherapeutics.com
High PointBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Description

vTv Therapeutics Inc. , a clinical stage biopharmaceutical company focused on the development of cadisegliatin as an adjunctive therapy to insulin for the treatment of type 1 diabetes , today announced the appointment of Thomas Strack, M.D. as Chief Medical Officer, effective immediately.

Quick answer

vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer (November 2, 2023). vTv Therapeutics Inc. is based in High Point, North Carolina, United States.

Who is the new Chief Medical Officer at vTv Therapeutics Inc?
vTv Therapeutics Inc. named Thomas Strack Chief Medical Officer, announced November 2, 2023.
What did vTv Therapeutics Inc. announce on November 2, 2023?
vTv Therapeutics Inc. , a clinical stage biopharmaceutical company focused on the development of cadisegliatin as an adjunctive therapy to insulin for the treatment of type 1 diabetes , today announced the appointment of Thomas Strack, M.D. as Chief Medical Officer, effective immediately.
What does vTv Therapeutics Inc. do?
vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by cadisegliatin (TTP399), a potential...
Where is vTv Therapeutics Inc. based?
vTv Therapeutics Inc. is based in High Point, North Carolina, United States.
Which similar companies made leadership changes around the same time?
Arbutus (November 7, 2023), Madrigal Pharmaceuticals (November 10, 2023), Dimerix Limited (October 23, 2023) and Chimerix (November 16, 2023) also announced leadership changes within 45 days of vTv Therapeutics Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at vTv Therapeutics Inc., and when

A new leader at vTv Therapeutics Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day vTv Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at vTv Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at vTv Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

vTv Therapeutics Inc.

Location

4170 MENDENHALL OAKS PKWY

High Point, North Carolina, United States

About

vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by cadisegliatin (TTP399), a potential adjunctive therapy to insulin for the treatment of type 1 diabetes. vTv’s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease, renal disease, primary mitochondrial myopathy, and glioblastoma and other cancers and cancer treatment-related conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment vTv Therapeutics Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Thomas
Likely contact at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for vTv Therapeutics Inc.'s next move

Learn about Strategic plan

vTv Therapeutics Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.